Kura Oncology (NASDAQ:KURA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Kura Oncology (KURA) operate in?

Kura Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kura Oncology Stock (NASDAQ: KURA) stock price, news, charts, stock research, profile.

Open	$19.87
Close	-
Volume / Avg.	115.16K / 636.94K
Day Range	$19.64 - $20.00
52 Wk Range	7.41 - 24.17
Market Cap	$1.50B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	14.17%
Days to Cover	24.15

Recent News

Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales

Avi Kapoor

Why Cancer-Drug Developer Kura Oncology Stock Is Up

Kura Oncology, Inc. shares are trading higher Tuesday after the company reported preliminary clinical data from the first 20 patients its Komet-007 Phase 1 dose-escalation trial. Kura reported that all newly diagnosed patients treated with ziftomenib and 7+3 achieved a complete remission (CR) with full count recovery, for a CR rate of 100% (5/5), including four patients with NPM1-m acute myeloid leukemia (AML) and one patient with KMT2A-r AML.

Erica Kollmann

General Motors Posts Upbeat Earnings, Joins Corning, HCA Healthcare And Other Big Stocks Moving Higher On Tuesday

U.S. stocks traded slightly lower, with the Dow Jones falling around 20 points on Tuesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

May

Jun

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$19.87
Close	-
Volume / Avg.	115.16K / 636.94K
Day Range	$19.64 - $20.00
52 Wk Range	7.41 - 24.17
Market Cap	$1.50B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	14.17%
Days to Cover	24.15

About Kura Oncology Inc

Sector

Health Care

Industry

Biotechnology

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and dev...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Kura Oncology (KURA) stock?

You can purchase shares of Kura Oncology (NASDAQ:KURA) through any online brokerage.

View our list of the best stock brokerages

Who are Kura Oncology (KURA) competitors?

Other companies in Kura Oncology’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Centessa Pharmaceuticals (NASDAQ:CNTA), Syndax Pharmaceuticals (NASDAQ:SNDX) and CareDx (NASDAQ:CDNA).

What is the forecast, or price target, for Kura Oncology (KURA) stock?

Kura Oncology has a consensus price target of $28.59.

What is the current price for Kura Oncology (KURA)?

The stock price for Kura Oncology (NASDAQ: KURA) is $19.625 last updated September 25, 2024 at 12:03 PM EDT.

Does Kura Oncology (KURA) pay a dividend?

There are no upcoming dividends for Kura Oncology.

When is Kura Oncology (NASDAQ:KURA) reporting earnings?

Kura Oncology’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Is Kura Oncology (KURA) going to split?

There is no upcoming split for Kura Oncology.

What sector and industry does Kura Oncology (KURA) operate in?

Kura Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge